Alnylam Pharmaceuticals Inc ALNY Phase 2 Diabetes Drug Progress and SP 500 Contender Status Lift Bullish Outlook FGBI First stock falls 296 after posting 95 Q4 2025 EPS miss against analyst consensus estimates SP Global Inc SPGI Unveils AIPowered Titan Platform and Expanded SLB Partnership to Reshape Energy Data Offerings